Alpha 2.0
Login Register
» Authors » S Tsuboi

S Tsuboi

Explore the profile of S Tsuboi including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 192
Citations 1422
Followers 0
Related Specialties
Biochemistry
Ophthalmology
General Medicine
Top 10 Co-Authors
Y Okada
S Ohmori
M Fukuda
H Nakagaki
M Namba
M Miyazaki
T KATSUTANI
T JYO
J E Pederson
K Emi
Published In
Chem Pharm Bull (Tokyo)
Invest Ophthalmol Vis Sci
J Biol Chem
Acta Med Okayama
Arerugi
Affiliations
Soon will be listed here.
Recent Articles
1.
Analysis of the linear oscillation dynamics of Fluidyne engines
Ito M, Murti P, Tsuboi S, Shoji E, Biwa T
J Acoust Soc Am . 2022 Mar; 151(2):1133. PMID: 35232089
A Fluidyne engine is a liquid piston Stirling engine that uses thermally induced self-sustained oscillations of water and air that are filled in a looped tube and tuning column. It...
2.
Long-term clinical impact of serum albumin in coronary artery disease patients with preserved renal function
Wada H, Dohi T, Miyauchi K, Shitara J, Endo H, Doi S, et al.
Nutr Metab Cardiovasc Dis . 2018 Jan; 28(3):285-290. PMID: 29289574
Background And Aims: Low serum albumin level is reportedly associated with worse clinical outcomes in patients with chronic kidney disease (CKD). However, associations between decreased serum albumin level and outcomes...
3.
Hypothyroidism associated with nivolumab treatment of unresectable malignant melanoma
Imafuku K, Yoshino K, Yamaguchi K, Tsuboi S, Ohara K, Hata H
Clin Exp Dermatol . 2017 Jan; 42(2):217-218. PMID: 28052364
No abstract available.
4.
Nivolumab therapy before vemurafenib administration induces a severe skin rash
Imafuku K, Yoshino K, Ymaguchi K, Tsuboi S, Ohara K, Hata H
J Eur Acad Dermatol Venereol . 2016 Aug; 31(3):e169-e171. PMID: 27546003
No abstract available.
5.
Structural Modification of the 6-Chloropyridyl Moiety in the Imidacloprid, Skeleton: Introduction of a Five-membered Heteroaromatic Ring and the Resulting Insecticidal Activity
Moriya K, Shibuya K, Hattori Y, Tsuboi S, Shiokawa K, Kagabu S
Biosci Biotechnol Biochem . 2016 Jun; 57(1):127-8. PMID: 27316887
No abstract available.
6.
A single-institution study examining cutaneous and non-cutaneous melanomas treated with nivolumab
Imafuku K, Yoshino K, Ishiwata K, Otobe S, Tsuboi S, Ohara K, et al.
J Eur Acad Dermatol Venereol . 2016 Feb; 30(12):e227-e229. PMID: 26841210
No abstract available.
7.
Lymphopenia can be a useful biomarker of adverse events related to vemurafenib
Imafuku K, Yoshino K, Ishiwata K, Ymaguchi K, Tsuboi S, Ohara K, et al.
J Eur Acad Dermatol Venereol . 2016 Jan; 31(1):e24-e26. PMID: 26810349
No abstract available.
8.
Severe rash associated with vemurafenib administration following nivolumab therapy
Imafuku K, Yoshino K, Ishiwata K, Otobe S, Tsuboi S, Ohara K, et al.
J Eur Acad Dermatol Venereol . 2015 Sep; 30(10):e84-e86. PMID: 26372833
No abstract available.
9.
Validity and reliability of a revised Japanese version of the Arthritis Impact Measurement Scales version 2 (AIMS2)
Sato H, Hashimoto A, Araki S, Nishibayashi Y, Hoshi K, Kutsuna T, et al.
Mod Rheumatol . 2014 Jan; 10(4):247-55. PMID: 24383638
Abstract This study aims to evaluate the validity and reliability of a Japanese version of the Arthritis Impact Measurement Scales, version 2 (AIMS2) for patients with rheumatoid arthritis (RA). The...
10.
Genetic polymorphisms in folate pathway enzymes as a possible marker for predicting the outcome of methotrexate therapy in Japanese patients with rheumatoid arthritis
Hayashi H, Fujimaki C, Daimon T, Tsuboi S, Matsuyama T, Itoh K
J Clin Pharm Ther . 2009 Oct; 34(3):355-61. PMID: 19827168
Background: Low-dose methotrexate (MTX) therapy is widely used in the treatment of rheumatoid arthritis (RA). Though the difference in response to MTX between patients with RA is large, the factors...